"Sylvester at Aventura is a hub for Sylvester’s innovative cancer services, providing uniquely tailored treatments for the most rare and challenging cancers. Our sub-specialized, multidisciplinary team is ready to work with you to offer the best outcomes for your patients. The team consists of 4 Hematology & Oncology Specialists and 2 Surgical Oncologists. This team is led by Dr. Joseph Pizzolato, who serves as the facility’s Medical Director."

During the past decade, UM Sylvester Comprehensive Cancer Center at Aventura conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UM Sylvester Comprehensive Cancer Center at Aventura" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UM Sylvester Comprehensive Cancer Center at Aventura" are "Clinical Stage IV Cutaneous Melanoma AJCC v8" (4 trials), "Pathologic Stage IV Cutaneous Melanoma AJCC v8" (3 trials), "Unresectable Melanoma" (3 trials), "Anatomic Stage II Breast Cancer AJCC v8" (2 trials) and "Anatomic Stage IIA Breast Cancer AJCC v8" (2 trials). Many other conditions were trialed in "UM Sylvester Comprehensive Cancer Center at Aventura" in a lesser frequency.

Most popular intervention types in "UM Sylvester Comprehensive Cancer Center at Aventura" are "Biological" (11 trials), "Drug" (9 trials), "Other" (8 trials), "Procedure" (6 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (5 trials), "Computed Tomography" (5 trials), "Nivolumab" (4 trials), "Pembrolizumab" (4 trials) and "Biopsy" (3 trials). Other intervention names were less common.

The vast majority of trials in "UM Sylvester Comprehensive Cancer Center at Aventura" are 14 trials for "All" genders.

Currently, there are NaN active trials in "UM Sylvester Comprehensive Cancer Center at Aventura". undefined are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UM Sylvester Comprehensive Cancer Center at Aventura, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UM Sylvester Comprehensive Cancer Center at Aventura, 3 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".